[1] |
Bares R,K 1 ever P, Hauptmann S, et al.F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer[J].Radiology, 1994, 192(1):79-86.
|
[2] |
Stollfuss JC, Glatting G, Friess H, et al.2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer:value of quantitative image interpretation[J].Radiology, 1995, 195(2):339-344.
|
[3] |
Inokuma T, Tamaki N, Torizuka T, et al.Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose:comparison with CT and U S[J].Radiology, 1995, 195(2):345-352.
|
[4] |
Friess H, Langhans J, Ebert M, et al.Diagnosis ofpancreatic cancer by 2 18F-fluoro-2-deoxy-D-glucosepositron emission tomography[J].Gut, 1995, 36(5):771-777.
|
[5] |
Zimny M,Bares R, Fass J, et al.Fluorine-18fluorodeoxyglucose positron emission tomography inthe defferential diagnosis of pancreatic carcinoma:areport of 106 cases[J].Eur J Nucl Med, 1997, 24(6):678-682.
|
[6] |
Keogan MT, Tyler D, Clark L, et al.Diagnosis ofpancreatic carcinoma:ro 1 e of FDG PET[J].Am J Roentgenol, 1998, 171(6):1565-1570.
|
[7] |
Diederichs CG, Staib L, Glatting G, et al.FDG PET:elevated plasma reduces both uptake and dection rateof pancreatic malignancies[J].J Nucl Med, 1998, 39:1030-1033.
|
[8] |
ShrevePD.Gross MD.Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease[J].Eur J Nucl Med, 1998, 25:259-264.
|
[9] |
Higashi T, Tamaki N, Honda T, et al.Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study[J], J Nucl Med, 1997, 38:1337-1344.
|
[10] |
Higashi T, Tamaki N, Honda T, et al.FDG uptake,GLU T-1 glucose transporter and cellularity in human pancreatic tumors[J].J Nucl Med, 1998, 39:1727-1735.
|
[11] |
Franke C, Klapdor R, Meyerhoff K, et al.18-FDG postrion emission tomography of the pancreas:diagnostic benefit in the following up of pancreatic carcinoma[J].Anticancer Res, 1999, 19:2437-2442.
|
[12] |
Kato T, Fukatsu H, Ito K, et al.Fluorodeoxyglucose positron emission tomography in pancreatic cancer:an unsolved problem[J].Eur J Nucl Med, 1995, 22:32-39.
|